Tatva Chintan Pharma Chem Ltd

Know More

1216.65-8.55 (-0.70%)

03:45 PM,4th Mar 2024

1218.60-7.05 (-0.58%)

04:01 PM,4th Mar 2024

BSE : 543321


Sector : Industrials

ISIN Code : INE0GK401011

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Mar 04 2024 | 04:01 PM IST

Market Cap (₹ Cr)


Turnover (₹ Cr)


Volume (Shares)


Face Value


52-WK High


52-WK High Date

03 Mar 2023

52-WK Low


52-WK Low Date

04 Mar 2024

All Time High


All Time High Date

03 Nov 2021

All Time Low


All Time Low Date

04 Mar 2024

Tatva Chintan Pharma Chem Ltd

The Company was formerly incorporated as Tatva Chintan Pharma Chem Private Limited in India on 12 June 1996 under the Companies Act 2013. The status of the Company got converted from Private Limited into a Public Limited Company effective from 27 January 2021 and consequently the name of Company also changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'. The Company is promoted by Mr. Chintan Nitin Kumar Shah Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is primarily engaged in manufacturing and selling of specialty chemicals Pharma & Agro intermediates and Quaternary Ammonium Compounds (Quats). The Company is a globally recognized specialty chemical player with several market leading products in its portfolio. Considering the wide application of products the Company supply products to leading global companies across diverse industries like automotive petroleum pharmaceutical agrochemicals paints and coatings dyes and pigments personal care and flavor and fragrances with over 1300 customers. Apart from customers in India the Company export products across the globe including USA China Germany Japan South Africa and UK. The Company operate through two world class manufacturing facilities located at Dahej and Ankleshwar in Gujarat both of which are strategically located very close to the Hazira Port. These units provide the Company cost and logistics advantage and enabling seamless export and import operations. The Company's manufacturing facilities obtained ISO 9001:2015 and 14001:2015 certification for robust quality management systems. Employing modern equipment like reactors assembly lines ANFDs centrifuges and RCVDs enabled the Company to undertake multiple chemistry process. The Company successfully established an integrated model comprising world class manufacturing infrastructure complex & chemical processes warehousing facilities and technically sound R&D capabilities which enables to achieve high operational efficiency and quality to innovate & customize and to ensure sustainable operations with wide offerings. The Company has sophisticated quality control lab equipped with modern analytical equipment enabling it to detect impurities upto PPM levels and achieve `ultra-pure'grade certification. The Company Promoters identified an opportunity in manufacturing Phase Transfer Catalyst (PTC) which is a niche segment within the specialty chemicals space. With PTC as the base the Company have marked presence in the entire value chain including PTC Structure Directing Agents (SDA) Electrolyte Salts (ES) and Pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC).The Company have a dedicated Department of Scientific and Industrial Research (DSIR) approved R&D centre at its Vadodara facility where qualified and experienced in-house R&D team focus on development of new products and improvement in current manufacturing processes. The Company is having modern systems and analytical development laboratory with state-of-the-art instrumentation.In 2004 the Company received licence from the FDA Gujarat at its Ankleshwar manufacturing plant.In 2007 the Company commenced Ankleshwar manufacturing facility and increased the expansion of manufacturing capacity.In 2011 the Company started commercial manufacturing of Structure Directing Agents (SDA).In 2015 the Company was accredited Appreciation Certificate for the Ankleshwar Plant from the Office of the Chief Commission of Central Excise Customs & Service Tax Vadodara Zone for its contribution to revenue and voluntary compliance with tax laws. The Company achieved revenue of nearly Rs 1 bn. The Company established a warehousing plant in The Netherlands. Tatva Chintan USA Inc. was incorporated as a wholly owned Subsidiary of TCPCL.In 2016 the Company was accorded the status of a two-star export house for the Ankleshwar plant from the Directorate General of Foreign Trade (DGFT) Ministry of Commerce and Industry (MoCI) Government of India (GoI).In 2017 manufacturing plant was established in Dahej Gujarat. In 2018 the R&D facility was set up in Vadodara.Tatva Chintan Europe BV was incorporated as wholly owned Subsidiary of the Company in year 2019.In FY 2019-20 the Company's Ankleshwar unit was converted to a zero liquid effluent discharge facility. The products proved efficiency to ensure lower by-products and waste generation in chemical processes.Additionally the Company participated in the ` Together for Sustainability' initiatives whereby sustainability sourcing practices of chemical suppliers like ecological and social aspects were assessed. Under this initiative the Company involved Ecovadis to audit sustainability practices and performance the results of which were above the industry average. This created a robust initiative and focused on retaining key customers who consider sustainability an important parameter to do business. In 2020 the Company achieved another Rs 2 billion revenue.In 2021 the manufacturing capacity at Dahej facility in Gujarat increased giving rise to aggregate installed reactor manufacturing capacity of the Company from 160 KL and 10 Assembly Lines to 280 KL and 17 Assembly Lines respectively.During the year 2021 the Company had issued 12052500 Equity Shares as Bonus Shares to all the existing shareholders of the Company in the ratio of 1.5:1 vide Board Resolution dated 03 March 2021 which was passed pursuant to passing of Special Resolution by Shareholders in ExtraOrdinary General Meeting held on 27 January 2021 against existing 8035000 Equity Shares.

Tatva Chintan Pharma Chem Ltd - Key Fundamentals

Market Cap (₹ Cr)


EPS - TTM (₹) [C]


P/E Ratio (X) [C]


Face Value (₹) 10
Latest Dividend (%)20.00
Latest Dividend Date 08 Sep 2023
Dividend Yield (%) 0.15
Book Value Share (₹) [C]310.94
P/B Ratio (₹) [C]3.91
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
Groww Nifty Total Market Index Fund-Regular (G) 0.00 39 0.00
Groww Nifty Total Market Index Fund-Direct (G) 0.00 39 0.00

Research Reports

Date BrokerActionPrices(Rs)Report
31-01-2023Nirmal Bang Accumulate 2176

Stock Strength

Today's Low/High



Week Low/High



Month Low/High



Year Low/High



All time Low/High



Share Price Returns

1 Week-3.22%-3.30%1.491.28%
1 Month-8.50%-8.59%2.482.52%
3 Month-21.08%-21.09%7.278.31%
6 Month-30.07%-30.03%12.5614.73%
1 Year-35.50%-35.39%23.5127.35%
3 Year%%45.2948.57%

Company Info

Company Information

Registered Office: No 502/17 GIDC Estate, Ankleshwar,Bharuch,Gujarat-393002 Ph: +91-75730-46951/46952